Kiniksa Pharmaceuticals International, plc (KNSA)
SEC fundamentals · as filed in 10-Q FY2026, period ended Sep 30, 2026 · updated Oct 30, 2026
as filed in 10-Q FY2026, period ended Sep 30, 2026 · View filings on EDGAR ↗
In its 10-Q for the period ended Sep 30, 2026, Kiniksa Pharmaceuticals International, plc reported revenue of $286.0M, net income of $47.3M, and total assets of $983.2M. Every figure below is taken directly from Kiniksa Pharmaceuticals International, plc's SEC filings: each links to the source document on EDGAR.
Revenue trend
Revenue · FY2021–FY2025 · as reported
- FY2021 revenue
- $38.5M
- FY2025 revenue
- $677.6M
Revenue and net income by fiscal year
As reported in each year’s annual filing · USD
| Fiscal year | Revenue | Net income |
|---|---|---|
| FY2025 | $677.6M | $59.0M |
| FY2024 | $423.2M | -$43.2M |
| FY2023 | $270.3M | $14.1M |
| FY2022 | $220.2M | $183.4M |
| FY2021 | $38.5M | -$157.9M |
| FY2020 | — | -$161.4M |
| FY2019 | — | -$161.9M |
| FY2018 | — | -$103.2M |
| FY2017 | — | -$64.9M |
Recent SEC filings
Filed by the registrant · newest first · insider forms and holder schedules not included
| Form | Filed | Source |
|---|---|---|
| 8-K | Oct 27, 2026 | on EDGAR ↗ |
| 10-Q | Oct 27, 2026 | on EDGAR ↗ |
| 8-K | Oct 22, 2026 | on EDGAR ↗ |
| 8-K | Jul 28, 2026 | on EDGAR ↗ |
| 10-Q | Jul 28, 2026 | on EDGAR ↗ |
| 8-K | May 29, 2026 | on EDGAR ↗ |
| 8-K | May 26, 2026 | on EDGAR ↗ |
| 8-K | May 1, 2026 | on EDGAR ↗ |
| 8-K | Apr 28, 2026 | on EDGAR ↗ |
| 10-Q | Apr 28, 2026 | on EDGAR ↗ |
Balance Sheet
as of Sep 30, 2026 · 10-Q
Income Statement
10-Q (quarterly) · period ended Sep 30, 2026
| Revenue | $286.0M | Revenue | source ↗ |
| Net Income | $47.3M | Net | source ↗ |
| Operating Income | $54.2M | Operating | source ↗ |
| Gross Profit | $258.2M | Revenue−Cost | source ↗ |
| Cost of Revenue | $27.8M | Cost | source ↗ |
| R&D Expense | $32.8M | Research | source ↗ |
Per Share & Cash Flow
10-Q (quarterly) · period ended Sep 30, 2026
| EPS (diluted) | $0.56 | Earnings | source ↗ |
| EPS (basic) | $0.61 | Earnings | source ↗ |
| Shares Outstanding | 83.7M | Weighted | source ↗ |
| Cash from Operations | $47.5M | Net | source ↗ |
| Cash from Financing | -$3.0M | Net | source ↗ |
| Cash from Investing | -$138.6M | Net | source ↗ |
Insider activity
Form 4 open-market activity, last 180 days
- Buys
- 0
- Sells
- 2
- Net shares
- -8.3K
Restatement history
Point-in-timeNo material restatements detected across 205 annual fact-keys: this company's as-filed numbers have held between filings. Point-in-time and as-of history are available via the API.
Deeper fundamentals
A free API key reaches KNSA’s revenue, margin and free-cash-flow trajectory (newest 3 fiscal years) and its leverage, liquidity and return ratios (newest 4 quarters). Analyst extends those to up to 20 years and 20 quarters, and adds the Piotroski F-score and accruals quality score. As-of fundamentals at any past date are on Free too, up to 10 lookups a day; Analyst removes that cap and adds the original-vs-restated detail, across the whole SEC universe.
Programmatic access
Everything on this page is served by the Distill API and by the MCP server at mcp.distillmarkets.com. A free key is issued at sign-up with no card; the full reference is in the docs.
- These fundamentals, as filed
- curlcurl -H "X-Api-Key: $DISTILL_API_KEY" \https://api.distillmarkets.com/api/v1/sec/fundamentals/KNSA
MCP tool:
get_sec_fundamentals ticker=KNSA - The same figures as they were known on any past date
- curlcurl -H "X-Api-Key: $DISTILL_API_KEY" \https://api.distillmarkets.com/api/v1/sec/fundamentals/KNSA/as-of/YYYY-MM-DD
MCP tool:
get_asof_fundamentals ticker=KNSA as_of=YYYY-MM-DD - Fiscal-year trajectory: revenue, margins, free cash flow
- curlcurl -H "X-Api-Key: $DISTILL_API_KEY" \https://api.distillmarkets.com/api/v1/sec/fundamentals/KNSA/history
MCP tool:
get_fundamentals_history ticker=KNSA - Leverage, liquidity, margin and return ratios
- curlcurl -H "X-Api-Key: $DISTILL_API_KEY" \https://api.distillmarkets.com/api/v1/sec/financial-health/KNSA
MCP tool:
get_financial_health ticker=KNSA
Not investment advice. Figures are shown as filed with the SEC; see the EDGAR source links for the original documents. Data may lag the latest filing.